Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A Knight-Swift Transportat Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Hamilton Insurance Group Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A PEOPLES BANCORP OF NORTH Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A FLUOR CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Sitio Royalties Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G CHEESECAKE FACTORY INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G US Foods Holding Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Champion Homes, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Haleon plc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A ATMOS ENERGY CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A CABOT CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MIDDLEBY Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A ANDINA BOTTLING CO INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G NXP Semiconductors N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Century Communities, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G TRACTOR SUPPLY CO /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MFA FINANCIAL, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Beta Bionics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Perella Weinberg Partner Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Douglas Emmett Inc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G HERITAGE COMMERCE CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A CHARLES RIVER LABORATORI Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Zai Lab Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A HAEMONETICS CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Archer-Daniels-Midland Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Taboola.com Ltd. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Crane NXT, Co. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A TPG Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A agilon health, inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A NORTHPOINTE BANCSHARES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A CLEAN HARBORS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A ROCKET PHARMACEUTICALS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G NORTHPOINTE BANCSHARES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A ROCKET PHARMACEUTICALS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A CLEAN HARBORS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Charles Schwab CEO says investors are cutting risk after April turmoil
-
Dataiku Brings AI Agent Creation and Control to The Universal AI Platform™
-
Wellington, Vanguard, and Blackstone to Collaborate on Investment Solutions Combining Public and Private Assets
-
Ann Gallo Joins Sword Health Board of Directors, Strengthening Strategic Leadership in Healthcare Innovation
-
Land & Buildings Sends Letter to National Health Investors (NHI) Stockholders and Files Definitive Proxy Materials Detailing Urgent Need for Boardroom Change
-
Land & Buildings Sends Letter to National Health Investors Stockholders and Files Definitive Proxy Materials Detailing Urgent Need for Boardroom Change
-
Form SCHEDULE 13G/A Autolus Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Customers Bancorp, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Analysis-Investors hunt for tariff-proof trades as new trade reality hits
-
Holding(s) in Company
-
Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs
-
Dataiku Achieves the AWS Generative AI Competency

